Purchase Order VA25017P0946
- Not listed
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Tri-Pharma, Inc., a minority-owned, small disadvantaged business, for the supply of GAMUNEX-C 10% 20GRAM/2MML VIAL. The contract has a ceiling value of $230,000.00 and an ultimate completion date of June 5, 2017. The contract is not designated as a set-aside. Tri-Pharma, Inc. is a Subchapter S Corporation that specializes in providing pharmaceuticals, personal protective equipment (PPE), and medical...
- This is a $80,620 firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Tri-Pharma, Inc., a minority-owned, small disadvantaged business. The contract is for the supply of the pharmaceutical product GAMMAGARD, and is designated as a total small business set-aside. Tri-Pharma specializes in providing a range of pharmaceuticals, personal protective equipment, and medical supplies to various federal agencies, including the VA, as well as the Department of Health...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the provision of medication. The contract has a ceiling value of $103,600.00 and is set aside for total small business participation. Tri-Pharma, Inc. is a supplier of pharmaceuticals, personal protective equipment (PPE), and medical supplies to various federal government agencies, including the VA, Department of Health and Human...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of pharmaceuticals. The $698,075.00 contract does not have a set-aside designation and was completed on June 3, 2019. Tri-Pharma, a specialty pharmaceutical wholesaler, has provided various pharmaceutical products and medical supplies to the VA and Department of Health and Human Services under previous...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $92,625.60 firm fixed-price delivery order is for the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the pharmaceutical product GAMUNEX-C, a 20 gram/200 ml vial, awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, with a ceiling value of $57,180.00, is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen, a major supplier of pharmaceutical and medical products to the federal government, is providing this specific medication...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,462.92 firm fixed price delivery order covers the supply of GAMUNEX-C 10 gram/100 ml vials, with a final completion date of January 6, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award is for the delivery of GAMUNEX-C, a 40-gram/400 ml vial of pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $23,272 and is a firm-fixed-price delivery order. The contract has an ultimate completion date of March 10, 2025 and was awarded on February 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a...
- This federal contract award, valued at $3,606.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 1 GRAM/10 ML VIAL 10ML, a pharmaceutical product, and has an ultimate completion date of November 21, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award, valued at $1,831.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 10 gram/100 ml vials, with a completion date of February 4, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award from the U.S. Department of Veterans Affairs (VA) is for the medication GAMUNEX-C, which is used for the treatment of primary immunodeficiency. The contract was awarded to Tri-Pharma, Inc., a minority-owned, self-certified small disadvantaged business. The contract has a ceiling value of $89,700.00 and is a firm-fixed-price purchase order with no set-aside designation. Tri-Pharma is a pharmaceutical supplier that provides a wide range of medical products, including personal protective equipment (PPE) and cleaning supplies, to various government agencies, including the VA, Department of Health and Human Services, and Department of the Army. The contract is not associated with a larger vehicle, and there is no information provided about any subcontractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $89.7k | 12/9/16 |